Cargando…
The prognostic and immunological role of MYB: from bladder cancer validation to pan-cancer analysis
Background: MYB proto-oncogene is verified as a transcription factor. Although emerging evidence showed that MYB plays a critical part in tumor progression and immunity, a systematic pan-cancer analysis of MYB still remains to be performed for determining whether MYB could serve as a biomarker for c...
Autores principales: | Cui, Xiaobo, Zhang, Chao, Zhang, Liqi, Yan, Huaqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086116/ https://www.ncbi.nlm.nih.gov/pubmed/36994664 http://dx.doi.org/10.1042/BSR20222627 |
Ejemplares similares
-
Comprehensive analysis of pan‐cancer reveals potential of ASF1B as a prognostic and immunological biomarker
por: Hu, Xinyao, et al.
Publicado: (2021) -
A five‐gene signature is a prognostic biomarker in pan‐cancer and related with immunologically associated extracellular matrix
por: Yu, Chunlai, et al.
Publicado: (2021) -
A pan-cancer analysis of prognostic genes
por: Anaya, Jordan, et al.
Publicado: (2016) -
Identification of m6A suppressor EIF4A3 as a novel cancer prognostic and immunotherapy biomarker through bladder cancer clinical data validation and pan-cancer analysis
por: Yan, Huaqing, et al.
Publicado: (2023) -
The comprehensive analysis of the prognostic and functional role of N-terminal methyltransferases 1 in pan-cancer
por: Tan, Lifan, et al.
Publicado: (2023)